Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Cancer drug development Drug prices

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Who’s winning in biotech’s tight market? - 7 days ago What pharma has learned from AI - about 2 months ago Amylyx’s CEOs on their ALS setback and quest to revamp the pipeline - 2 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 3 months ago Behind a big-name rare disease biotech, an exec draws from personal experience - 7 months ago Astellas’ science chief on the leap into new technologies - 7 months ago ‘1 plus 1 equals 3’ — the co-CEO model in pharma - 8 months ago The biggest questions hanging over pharma in 2024 - 8 months ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - 8 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - 8 months ago A former CDC head on key R&D areas, public trust and if we learned anything from COVID-19 - 9 months ago Does BioMarin’s CEO shuffle signal bigger changes ahead? - 11 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - 11 months ago The 2023 Red Jacket honorees - 11 months ago PharmaVoice 100s: Clinical trial gurus - 11 months ago The PharmaVoice 100: Standout execs - 12 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	BioMarin’s big day today - 16 days ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Read to lead: 6 books pharma execs swear by - about 2 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 4 months ago 4 offbeat biotechs making a splash in the life sciences - 5 months ago How a biotech exec is leveraging Big Pharma lessons to advance tRNA - 5 months ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs - about 2 months ago
5	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - about 2 months ago STAT+: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline - 6 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - 11 months ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 4 months ago Lawmakers want to add more Chinese biotechs to defense list - 6 months ago What do CEOs owe the world? - 7 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 9 months ago FDA chastens pet companies over antibiotics - 9 months ago Novartis is building a new radioligand plant in China - 10 months ago Johnson & Johnson bets heavy on AI-driven drug discovery - 10 months ago Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO - 11 months ago
7	Robert Weisman — Boston Globe STAT News Staff writer at Boston Globe. Tracks biotech. Boston biotechlife sciences	STAT+: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership - 7 months ago STAT+: Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech - 7 months ago STAT+: Veteran biotech entrepreneur Harvey Berger to lead startup Kojin Therapeutics - 9 months ago
8	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health - 7 months ago 4 biotechs to watch in 2024 - 7 months ago Rise of the chief investment officer: Why the unique role works for Roivant - 9 months ago The biopharma COO’s playbook - 10 months ago The power of genomics-based healthcare remains largely untapped - 10 months ago 5 of the best paid biopharma CEOs - 10 months ago 23andMe CEO Anne Wojcicki’s vision for changing healthcare as a ‘full-fledged biotech’ - 11 months ago Red Jacket: Dr. Mark Goldberg, a clinical innovator - 11 months ago
9	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	Vaxxinity is brewing up meds for a spacefaring future - 8 months ago
10	Rachel Cohrs STAT News Washington Correspondent @statnews. Washington, DC health policyjournalism	STAT+: Another major pharma company departs BIO - 9 months ago STAT+: Pfizer plans to depart BIO - 10 months ago STAT+: BIO selects rare disease advocate, biotech executive John Crowley as new CEO - 10 months ago

Journalists covering biotech leadership